Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study

Fabrice Barlesi,A. Dixmier,Didier Debieuvre,Christophe Raspaud,Jean Bernard Auliac,Nicolas Benoit,P. Bombaron,Denis Moro-Sibilot,Clarisse Audigier Valette,Bernard Asselain,Thomas Egenod,Audrey Rabeau,Jérôme Fayette,Myriam Locatelli-Sanchez,Jean-Luc Labourey,Virginie Westeel,Pauline Lamoureux,François-Emery Cotté,Victoria Allan,M Daumont,Juliette Dumanoir,Dorothee Reynaud,C. Calvet,N. Ozan,Maurice Pérol

Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study

2020

EVIDENS is an ongoing, prospective, non-interventional study evaluating the effectiveness and safety of nivolumab in lung cancer patients in France (ClinicalTrials.gov NCT03382496).Adults with a pa...

Keywords:

Treatment of lung cancer
Medicine
Cancer research
Nivolumab
Lung cancer
Observational study
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations